| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
|
Agulnik, Mark
|
|
|
154 |
C |
p. 201-208
|
artikel
|
| 2 |
A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy
|
Choi, In Sil
|
|
|
154 |
C |
p. 288-295
|
artikel
|
| 3 |
Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update
|
Patel, Priya
|
|
|
154 |
C |
p. 92-101
|
artikel
|
| 4 |
Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial
|
Denda, Tadamichi
|
|
|
154 |
C |
p. 296-306
|
artikel
|
| 5 |
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
|
Fazio, Nicola
|
|
|
154 |
C |
p. 246-252
|
artikel
|
| 6 |
Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study
|
Placke, Jan-Malte
|
|
|
154 |
C |
p. 167-174
|
artikel
|
| 7 |
Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
|
Barrière, Jérôme
|
|
|
154 |
C |
p. 66-72
|
artikel
|
| 8 |
Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial
|
Smith, Matthew R.
|
|
|
154 |
C |
p. 138-146
|
artikel
|
| 9 |
Deep learning approach to predict sentinel lymph node status directly from routine histology of primary melanoma tumours
|
Brinker, Titus J.
|
|
|
154 |
C |
p. 227-234
|
artikel
|
| 10 |
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
|
Hartkopf, Andreas D.
|
|
|
154 |
C |
p. 128-137
|
artikel
|
| 11 |
Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial
|
Arun, Banu K.
|
|
|
154 |
C |
p. 35-45
|
artikel
|
| 12 |
Efficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the short or medium-term: overview of systematic reviews
|
Salazar, Josefina
|
|
|
154 |
C |
p. 82-91
|
artikel
|
| 13 |
Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib
|
Saiag, Philippe
|
|
|
154 |
C |
p. 57-65
|
artikel
|
| 14 |
Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas
|
Kantidakis, Georgios
|
|
|
154 |
C |
p. 253-268
|
artikel
|
| 15 |
European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer
|
van Kalsbeek, Rebecca J.
|
|
|
154 |
C |
p. 316-328
|
artikel
|
| 16 |
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial
|
Guarneri, Valentina
|
|
|
154 |
C |
p. 21-29
|
artikel
|
| 17 |
Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)
|
Pereira, Helena
|
|
|
154 |
C |
p. 46-56
|
artikel
|
| 18 |
High levels of anti–SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine
|
Fong, Dominic
|
|
|
154 |
C |
p. 4-6
|
artikel
|
| 19 |
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
|
Massari, Francesco
|
|
|
154 |
C |
p. 120-127
|
artikel
|
| 20 |
Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis
|
Jiménez, Irene
|
|
|
154 |
C |
p. 277-287
|
artikel
|
| 21 |
New drugs and options can enhance patient outcomes: But can they also erode them?
|
Kim, Myung S.
|
|
|
154 |
C |
p. 1-3
|
artikel
|
| 22 |
OncotypeDX© Recurrence Score in BRCA mutation carriers: a systematic review and meta-analysis
|
Davey, Matthew G.
|
|
|
154 |
C |
p. 209-216
|
artikel
|
| 23 |
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer
|
Yuan, Yuan
|
|
|
154 |
C |
p. 11-20
|
artikel
|
| 24 |
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies
|
Lim, Kian-Huat
|
|
|
154 |
C |
p. 102-110
|
artikel
|
| 25 |
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy
|
Tjokrowidjaja, Angelina
|
|
|
154 |
C |
p. 190-200
|
artikel
|
| 26 |
Prognostic value of tumour-infiltrating lymphocytes based on the evaluation of frequency in patients with oestrogen receptor–positive breast cancer
|
He, Jiajia
|
|
|
154 |
C |
p. 217-226
|
artikel
|
| 27 |
Psychometric validation of the European Organisation for Research and Treatment of Cancer–Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22)
|
Greimel, Elfriede
|
|
|
154 |
C |
p. 235-245
|
artikel
|
| 28 |
Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201
|
Yamamoto, Sachiko
|
|
|
154 |
C |
p. 307-315
|
artikel
|
| 29 |
Risk for infections with selinexor in patients with relapsed/refractory multiple myeloma: a systematic review of clinical trials
|
Abid, Haisam
|
|
|
154 |
C |
p. 7-10
|
artikel
|
| 30 |
Sexual dysfunction in young adult survivors of childhood cancer – A population-based study
|
Hovén, Emma
|
|
|
154 |
C |
p. 147-156
|
artikel
|
| 31 |
Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003–2018): A nationwide population-based study
|
Leeneman, Brenda
|
|
|
154 |
C |
p. 111-119
|
artikel
|
| 32 |
Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry
|
Yamada, Akimitsu
|
|
|
154 |
C |
p. 157-166
|
artikel
|
| 33 |
The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience
|
Revon-Riviere, Gabriel
|
|
|
154 |
C |
p. 30-34
|
artikel
|
| 34 |
The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: A systematic review
|
Diab, Hadi M.H.
|
|
|
154 |
C |
p. 73-81
|
artikel
|
| 35 |
The role of tyrosine kinase inhibitors in the treatment of HER2+ metastatic breast cancer
|
Le Du, Fanny
|
|
|
154 |
C |
p. 175-189
|
artikel
|
| 36 |
Younger age at onset of colorectal cancer is associated with increased patient’s delay
|
Rydbeck, Daniel
|
|
|
154 |
C |
p. 269-276
|
artikel
|
Tijdschrift beschrijving